The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – ...

First GLP-1 pill approved in the European Union for the treatment of obesity and overweightOnly Wegovy® pill demonstrates 17% ...

Novo Nordisk (NVO) stock gains as the EU approves the Wegovy pill and higher-dose single-pen version of injectable Wegovy. Read more here.

Wegovy pill? No thanks – I wouldn’t take it if you paid me - COMMENT: Needle-free weight loss has arrived in the UK, prompting a surge of interest from pharmacy customers. But after taking injectable ...

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk that is approved by the U.S. Food ...

Novo Nordisk wins EC approval for a once-daily oral Wegovy pill for obesity, expanding its EU franchise with the first GLP-1 ...

The Wegovy weight loss pill offers patients a new alternative to weekly injections ...

The Wegovy weight loss pill is the UK's first GLP-1 weight-loss tablet and offers patients a new alternative to weekly weight ...

The Wegovy pill contains semaglutide, the same active ingredient used in the Wegovy injection, but is taken once a day as a ...

The Wegovy weight loss pill is now available to buy in the UK, offering patients access to GLP-1 semaglutide medication ...

A pharmacist has warned that patients interested in the new Wegovy pill may not be getting the full picture on the strict ...

For an ALS patient, losing weight can cause the condition to progress faster.